Assembling the Tat protein translocase

  1. Felicity Alcock
  2. Phillip J Stansfeld  Is a corresponding author
  3. Hajra Basit
  4. Johann Habersetzer
  5. Matthew AB Baker
  6. Tracy Palmer
  7. Mark I Wallace
  8. Ben C Berks  Is a corresponding author
  1. University of Oxford, United Kingdom
  2. Kings College London, United Kingdom
  3. University of Dundee, United Kingdom
  4. University of New South Wales, Australia

Abstract

The twin-arginine protein translocation system (Tat) transports folded proteins across the bacterial cytoplasmic membrane and the thylakoid membranes of plant chloroplasts. The Tat transporter is assembled from multiple copies of the membrane proteins TatA, TatB, and TatC. We combine sequence co-evolution analysis, molecular simulations, and experimentation to define the interactions between the Tat proteins of Escherichia coli at molecular-level resolution. In the TatBC receptor complex the transmembrane helix of each TatB molecule is sandwiched between two TatC molecules, with one of the inter-subunit interfaces incorporating a functionally important cluster of interacting polar residues. Unexpectedly, we find that TatA also associates with TatC at the polar cluster site. Our data provide a structural model for assembly of the active Tat translocase in which substrate binding triggers replacement of TatB by TatA at the polar cluster site. Our work demonstrates the power of co-evolution analysis to predict protein interfaces in multi-subunit complexes.

Article and author information

Author details

  1. Felicity Alcock

    Department of Biochemistry, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Phillip J Stansfeld

    Department of Biochemistry, University of Oxford, Oxford, United Kingdom
    For correspondence
    phillip.stansfeld@bioch.ox.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  3. Hajra Basit

    Department of Chemistry, Kings College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Johann Habersetzer

    Division of Molecular Microbiology, College of Life Sciences, University of Dundee, Dundee, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Matthew AB Baker

    EMBL Australia Node for Single Molecule Science, University of New South Wales, Kensington, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Tracy Palmer

    Division of Molecular Microbiology, College of Life Sciences, University of Dundee, Dundee, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Mark I Wallace

    Department of Chemistry, Kings College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5692-8313
  8. Ben C Berks

    Department of Biochemistry, University of Oxford, Oxford, United Kingdom
    For correspondence
    ben.berks@bioch.ox.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9685-4067

Funding

Biotechnology and Biological Sciences Research Council (BB/L002531/1)

  • Tracy Palmer
  • Ben C Berks

Wellcome (Investigator Award 107929/Z/15/Z)

  • Ben C Berks

Medical Research Council (G1001640)

  • Tracy Palmer
  • Ben C Berks

European Commission (Marie Curie Fellowship Programme: GP7-PEOPLE-2013-IEF 626436)

  • Hajra Basit
  • Mark I Wallace

Biotechnology and Biological Sciences Research Council (BB/I019855/1)

  • Phillip J Stansfeld

Wellcome (Investigator Award 110183/Z/15/Z)

  • Tracy Palmer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Nir Ben-Tal, Tel Aviv University, Israel

Publication history

  1. Received: August 22, 2016
  2. Accepted: November 29, 2016
  3. Accepted Manuscript published: December 3, 2016 (version 1)
  4. Accepted Manuscript updated: December 16, 2016 (version 2)
  5. Accepted Manuscript updated: December 20, 2016 (version 3)
  6. Version of Record published: December 30, 2016 (version 4)

Copyright

© 2016, Alcock et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,991
    Page views
  • 785
    Downloads
  • 45
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Felicity Alcock
  2. Phillip J Stansfeld
  3. Hajra Basit
  4. Johann Habersetzer
  5. Matthew AB Baker
  6. Tracy Palmer
  7. Mark I Wallace
  8. Ben C Berks
(2016)
Assembling the Tat protein translocase
eLife 5:e20718.
https://doi.org/10.7554/eLife.20718

Further reading

    1. Biochemistry and Chemical Biology
    Loïc Duffet, Elyse T Williams ... Tommaso Patriarchi
    Tools and Resources

    The glucagon-like peptide-1 receptor (GLP1R) is a broadly expressed target of peptide hormones with essential roles in energy and glucose homeostasis, as well as of the blockbuster weight-loss drugs semaglutide and liraglutide. Despite its large clinical relevance, tools to investigate the precise activation dynamics of this receptor with high spatiotemporal resolution are limited. Here, we introduce a novel genetically encoded sensor based on the engineering of a circularly permuted green fluorescent protein into the human GLP1R, named GLPLight1. We demonstrate that fluorescence signal from GLPLight1 accurately reports the expected receptor conformational activation in response to pharmacological ligands with high sensitivity (max ΔF/F0=528%) and temporal resolution (τON = 4.7 s). We further demonstrated that GLPLight1 shows comparable responses to glucagon-like peptide-1 (GLP-1) derivatives as observed for the native receptor. Using GLPLight1, we established an all-optical assay to characterize a novel photocaged GLP-1 derivative (photo-GLP1) and to demonstrate optical control of GLP1R activation. Thus, the new all-optical toolkit introduced here enhances our ability to study GLP1R activation with high spatiotemporal resolution.

    1. Biochemistry and Chemical Biology
    2. Immunology and Inflammation
    Minato Hirano, Gaddiel Galarza-Muñoz ... Mariano A Garcia-Blanco
    Research Article

    Genes associated with increased susceptibility to multiple sclerosis (MS) have been identified, but their functions are incompletely understood. One of these genes codes for the RNA helicase DExD/H-Box Polypeptide 39B (DDX39B), which shows genetic and functional epistasis with interleukin-7 receptor-α gene (IL7R) in MS-risk. Based on evolutionary and functional arguments, we postulated that DDX39B enhances immune tolerance thereby decreasing MS risk. Consistent with such a role we show that DDX39B controls the expression of many MS susceptibility genes and important immune-related genes. Among these we identified Forkhead Box P3 (FOXP3), which codes for the master transcriptional factor in CD4+/CD25+ T regulatory cells. DDX39B knockdown led to loss of immune-regulatory and gain of immune-effector expression signatures. Splicing of FOXP3 introns, which belong to a previously unrecognized type of introns with C-rich polypyrimidine tracts, was exquisitely sensitive to DDX39B levels. Given the importance of FOXP3 in autoimmunity, this work cements DDX39B as an important guardian of immune tolerance.